| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | CN1293655A Bicyclo [2.2.1] heptanes and related compounds |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293060A Chinese medicine for treating baby diarrhea and its preparing process |
| 05/02/2001 | CN1293054A Medicine for treating hepatism and its preparing process |
| 05/02/2001 | CN1293048A Method for treating hepatism with lotus root |
| 05/02/2001 | CN1293046A Medicine for curing gastroenteropathy and its preparing process |
| 05/02/2001 | CN1293044A Pills for treating gastropathy |
| 05/02/2001 | CN1293041A Functional food for protecting liver and medicine for preventing and curing hepatitides prepared from loach and its preparing process |
| 05/02/2001 | CN1065244C Tricyclic benzazepine vasopressin antagonists |
| 05/02/2001 | CN1065134C Medicine for treatment of stone |
| 05/01/2001 | US6225486 Composition comprising mixture of free fatty acid conjugated linoleic acid isomers containing at least approximately 92 per cent trans 10, cis 12-octadecadienoic acid |
| 05/01/2001 | US6225481 Robustaflavone, intermediates and analogues and method for preparation thereof |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225355 Process for removing bile salts from a patient and alkylated compositions therefor |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | US6225302 Amidino protease inhibitors |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225104 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 04/27/2001 | CA2324538A1 Gastric acid secretion |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029066A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029041A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029039A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | WO2001029034A1 Quinuclidine acrylamides |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029027A1 2-alkoxybenzene derivatives |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029007A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | WO2001028586A1 Method of treating fibrosis |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028558A1 Formulation of substituted benzimidazoles |
| 04/26/2001 | WO2001028557A1 Cannabimimetic indole derivatives |
| 04/26/2001 | WO2001028543A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
| 04/26/2001 | WO2001028538A2 Laxative preparation containing l-arginine |
| 04/26/2001 | WO2001028523A1 Powder pharmaceutical formulations |
| 04/26/2001 | WO2001028515A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | WO2001028498A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | WO2001028497A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19950933A1 Use of St. John's wort constituents for photodynamic diagnosis and/or therapy of mouth and malignant brain disorders |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388315A1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387786A1 Treatment of eosinophil associated pathologies by modulating pkc-.delta. activity |
| 04/26/2001 | CA2387392A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | CA2386422A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | CA2386149A1 Allosteric sites on muscarinic receptors |
| 04/26/2001 | CA2385958A1 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | CA2384789A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093821A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093380A2 Component b as angiogenic agent in combination with human growth factors |
| 04/25/2001 | EP1093374A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292697A Anti-viral compound |
| 04/25/2001 | CN1292287A Adhesive plaster for curing stomach-ache and abdominal pain |
| 04/25/2001 | CN1292282A Medicated liquor for curing chronic gastritis and gastric ulcer |
| 04/25/2001 | CN1292280A Functional tonifying health-care product produced by utilizing enzyme engineering and its preparation method |
| 04/25/2001 | CN1292278A Weisushukang medicine for curing gastropathy and its preparation process |
| 04/25/2001 | CN1292269A Quick-acting powder preparation for curing toothache |
| 04/25/2001 | CN1292267A Medicine for curing gastropathy and its preparation method |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |